Ocrelizumab in pediatric multiple sclerosis

Amirov, CB; Saltik, S; Yalçinkaya, C; Tütüncü, M; Saip, S; Siva, A; Uygunoglu, U

Uygunoglu, U (通讯作者)，Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Neurol, Istanbul, Turkiye.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023; 43 (): 1

Abstract

Background: Ocrelizumab is a recombinant humanized anti-CD20 monoclonal IgG1, approved by FDA and EMA for adult patients with multiple sclerosis (MS).......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索